• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于包载槲皮素的含非离子表面活性剂的脂质体和液晶脂质纳米粒的研制。

Development of Liposomal and Liquid Crystalline Lipidic Nanoparticles with Non-Ionic Surfactants for Quercetin Incorporation.

作者信息

Tsichlis Ioannis, Manou Athanasia-Paraskevi, Manolopoulou Vasiliki, Matskou Konstantina, Chountoulesi Maria, Pletsa Vasiliki, Xenakis Aristotelis, Demetzos Costas

机构信息

Section of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimioupolis Zografou, 15771 Athens, Greece.

Institute of Chemical Biology, National Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece.

出版信息

Materials (Basel). 2023 Aug 8;16(16):5509. doi: 10.3390/ma16165509.

DOI:10.3390/ma16165509
PMID:37629800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10456281/
Abstract

The aim of the present study is the development, physicochemical characterization, and in vitro cytotoxicity evaluation of both empty and quercetin-loaded HSPC (hydrogenated soy phosphatidylcholine) liposomes, GMO (glyceryl monooleate) liquid crystalline nanoparticles, and PHYT (phytantriol) liquid crystalline nanoparticles. Specifically, HSPC phospholipids were mixed with different non-ionic surfactant molecules (Tween 80 and/or Span 80) for liposomal formulations, whereas both GMO and PHYT lipids were mixed with Span 80 and Tween 80 as alternative stabilizers, as well as with Poloxamer P407 in different ratios for liquid crystalline formulations. Subsequently, their physicochemical properties, such as size, size distribution, and ζ-potential were assessed by the dynamic and electrophoretic light scattering (DLS/ELS) techniques in both aqueous and biological medium with serum proteins. The in vitro biological evaluation of the empty nanosystems was performed by using the MTT cell viability and proliferation assay. Finally, the entrapment efficiency of quercetin was calculated and the differences between the two different categories of lipidic nanoparticles were highlighted. According to the results, the incorporation of the non-ionic surfactants yields a successful stabilization and physicochemical stability of both liposomal and liquid crystalline nanoparticles. Moreover, in combination with an appropriate biosafety in vitro profile, increased encapsulation efficiency of quercetin was achieved. Overall, the addition of surfactants improved the nanosystem's stealth properties. In conclusion, the results indicate that the physicochemical properties were strictly affected by the formulation parameters, such as the type of surfactant.

摘要

本研究的目的是对空白和载有槲皮素的氢化大豆磷脂酰胆碱(HSPC)脂质体、甘油单油酸酯(GMO)液晶纳米粒和植烷三醇(PHYT)液晶纳米粒进行开发、理化特性表征及体外细胞毒性评估。具体而言,将HSPC磷脂与不同的非离子表面活性剂分子(吐温80和/或司盘80)混合用于脂质体制剂,而将GMO和PHYT脂质与司盘80和吐温80作为替代稳定剂混合,以及与泊洛沙姆P407以不同比例混合用于液晶体制剂。随后,通过动态和电泳光散射(DLS/ELS)技术在含有血清蛋白的水性和生物介质中评估它们的理化性质,如尺寸、尺寸分布和ζ电位。通过MTT细胞活力和增殖测定对空白纳米系统进行体外生物学评估。最后,计算槲皮素的包封率,并突出两种不同类型脂质纳米粒之间的差异。根据结果,非离子表面活性剂的加入使脂质体和液晶纳米粒都成功实现了稳定化和理化稳定性。此外,结合适当的体外生物安全性,槲皮素的包封效率有所提高。总体而言,表面活性剂的加入改善了纳米系统的隐身性能。总之,结果表明理化性质受到制剂参数(如表面活性剂类型)的严格影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ae/10456281/bec870fa5518/materials-16-05509-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ae/10456281/35283e7296df/materials-16-05509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ae/10456281/76b2090ba67e/materials-16-05509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ae/10456281/23c772f3ae54/materials-16-05509-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ae/10456281/a0d80473cc06/materials-16-05509-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ae/10456281/bec870fa5518/materials-16-05509-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ae/10456281/35283e7296df/materials-16-05509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ae/10456281/76b2090ba67e/materials-16-05509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ae/10456281/23c772f3ae54/materials-16-05509-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ae/10456281/a0d80473cc06/materials-16-05509-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ae/10456281/bec870fa5518/materials-16-05509-g006a.jpg

相似文献

1
Development of Liposomal and Liquid Crystalline Lipidic Nanoparticles with Non-Ionic Surfactants for Quercetin Incorporation.用于包载槲皮素的含非离子表面活性剂的脂质体和液晶脂质纳米粒的研制。
Materials (Basel). 2023 Aug 8;16(16):5509. doi: 10.3390/ma16165509.
2
Chimeric liposomes decorated with P407: an alternative biomaterial for producing stealth nano-therapeutics.载有 P407 的嵌合脂质体:用于制备隐形纳米治疗药物的新型生物材料。
J Liposome Res. 2022 Mar;32(1):83-91. doi: 10.1080/08982104.2021.1978486. Epub 2021 Nov 29.
3
The Influence of Hydrophobic Blocks of PEO-Containing Copolymers on Glyceryl Monooleate Lyotropic Liquid Crystalline Nanoparticles for Drug Delivery.含聚环氧乙烷共聚物的疏水嵌段对用于药物递送的单油酸甘油酯溶致液晶纳米颗粒的影响。
Polymers (Basel). 2021 Aug 5;13(16):2607. doi: 10.3390/polym13162607.
4
Liquid crystalline nanoparticles for drug delivery: The role of gradient and block copolymers on the morphology, internal organisation and release profile.用于药物递送的液晶纳米颗粒:梯度共聚物和嵌段共聚物对形态、内部结构及释放曲线的作用
Eur J Pharm Biopharm. 2021 Jan;158:21-34. doi: 10.1016/j.ejpb.2020.08.008. Epub 2020 Oct 22.
5
Comprehensive and comparative studies on nanocytotoxicity of glyceryl monooleate- and phytantriol-based lipid liquid crystalline nanoparticles.甘油单油酸酯和植物三醇基脂质液晶纳米颗粒的纳米细胞毒性的综合比较研究。
J Nanobiotechnology. 2021 Jun 3;19(1):168. doi: 10.1186/s12951-021-00913-5.
6
Development of stimuli-responsive lyotropic liquid crystalline nanoparticles targeting lysosomes: Physicochemical, morphological and drug release studies.靶向溶酶体的响应性溶致液晶纳米粒的研制:物理化学、形态学和药物释放研究。
Int J Pharm. 2023 Jan 5;630:122440. doi: 10.1016/j.ijpharm.2022.122440. Epub 2022 Nov 25.
7
Preparation and characterization of quercetin-loaded lipid liquid crystalline systems.载槲皮素脂质液晶体系的制备与表征
Colloids Surf B Biointerfaces. 2015 Apr 1;128:296-303. doi: 10.1016/j.colsurfb.2015.02.001. Epub 2015 Feb 9.
8
Non-Ionic Surfactant Effects on Innate Pluronic 188 Behavior: Interactions, and Physicochemical and Biocompatibility Studies.非离子型表面活性剂对天然普朗尼克 188 行为的影响:相互作用及理化和生物相容性研究。
Int J Mol Sci. 2022 Nov 10;23(22):13814. doi: 10.3390/ijms232213814.
9
Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles.重新审视 β-酪蛋白作为脂质液晶纳米结构颗粒的稳定剂。
Langmuir. 2011 Dec 20;27(24):14757-66. doi: 10.1021/la203061f. Epub 2011 Nov 18.
10
Formulation and evaluation of solid lipid nanoparticles of ramipril.雷米普利固体脂质纳米粒的制备与评价
J Young Pharm. 2011 Jul;3(3):216-20. doi: 10.4103/0975-1483.83765.

引用本文的文献

1
Phytochemical-based nanosystems: recent advances and emerging application in antiviral photodynamic therapy.基于植物化学物质的纳米系统:抗病毒光动力疗法的最新进展与新兴应用
Nanomedicine (Lond). 2025 Feb;20(4):401-416. doi: 10.1080/17435889.2025.2452151. Epub 2025 Jan 23.

本文引用的文献

1
Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases.眼部给药系统的最新进展:眼用植入物在慢性眼病治疗中的突出地位。
Pharmaceutics. 2023 Jun 15;15(6):1746. doi: 10.3390/pharmaceutics15061746.
2
Recent Advances in Nanoformulations for Quercetin Delivery.槲皮素递送纳米制剂的最新进展
Pharmaceutics. 2023 Jun 5;15(6):1656. doi: 10.3390/pharmaceutics15061656.
3
Development of stimuli-responsive lyotropic liquid crystalline nanoparticles targeting lysosomes: Physicochemical, morphological and drug release studies.
靶向溶酶体的响应性溶致液晶纳米粒的研制:物理化学、形态学和药物释放研究。
Int J Pharm. 2023 Jan 5;630:122440. doi: 10.1016/j.ijpharm.2022.122440. Epub 2022 Nov 25.
4
Progress and challenges of lyotropic liquid crystalline nanoparticles for innovative therapies.溶致液晶纳米粒用于创新疗法的研究进展与挑战
Int J Pharm. 2022 Nov 25;628:122299. doi: 10.1016/j.ijpharm.2022.122299. Epub 2022 Oct 17.
5
pH-Sensitive Twin Liposomes Containing Quercetin and Laccase for Tumor Therapy.载有槲皮素和漆酶的 pH 敏感双脂质体用于肿瘤治疗。
Biomacromolecules. 2022 Sep 12;23(9):3688-3697. doi: 10.1021/acs.biomac.2c00571. Epub 2022 Aug 17.
6
Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of JAK2 Via the JAK2-STAT3-PDL1.槲皮素包封在叶酸修饰的脂质体中通过非共价结合到 JAK2 的 JH2 结构域,通过 JAK2-STAT3-PDL1 途径发挥治疗骨肉瘤的作用。
Pharmacol Res. 2022 Aug;182:106287. doi: 10.1016/j.phrs.2022.106287. Epub 2022 Jun 6.
7
Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.溶致液晶纳米结构作为药物递送系统和疫苗平台
Pharmaceuticals (Basel). 2022 Mar 31;15(4):429. doi: 10.3390/ph15040429.
8
Quercetin loaded liposomes modified with galactosylated chitosan prevent LPS/D-GalN induced acute liver injury.载姜黄素脂质体经半乳糖化壳聚糖修饰可预防脂多糖/二氨基半乳糖诱导的急性肝损伤。
Mater Sci Eng C Mater Biol Appl. 2021 Dec;131:112527. doi: 10.1016/j.msec.2021.112527. Epub 2021 Oct 27.
9
Chimeric liposomes decorated with P407: an alternative biomaterial for producing stealth nano-therapeutics.载有 P407 的嵌合脂质体:用于制备隐形纳米治疗药物的新型生物材料。
J Liposome Res. 2022 Mar;32(1):83-91. doi: 10.1080/08982104.2021.1978486. Epub 2021 Nov 29.
10
Development of niosomes for encapsulating captopril-quercetin prodrug to combat hypertension.用于包裹卡托普利-槲皮素前药以治疗高血压的尼奥斯omes 的开发。
Int J Pharm. 2021 Nov 20;609:121191. doi: 10.1016/j.ijpharm.2021.121191. Epub 2021 Oct 17.